HOME  | CONTACT  | PATIENT LOGIN  | CLINIC LOGIN  | FAQ
  • PATIENTS &
    HEALTHY VOLUNTEERS
  • INVESTIGATORS
  • CROS / SPONSORS
  • CAREERS
  • TRIAL ALERTS

TRIALS SEARCH
      
  • HEALTH NEWS

  • RSS FEEDS

  • ABOUT TRIALS

  • LINK TO US


View Clinical Trial (Medical Research Study)


A Stage 1 Study of Community Reinforcement and Family Training for Treatment Drug Abuse Treatment Retention/HIV Risk Reduction

This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials

Signup
Browse Studies

City:   Columbus
State:   Ohio
Zip Code:   43207
Conditions:   Heroin Dependence - Opiate Dependence - Substance Dependence
Purpose:   The planned research will adapt an intervention of known efficacy to target a new outcome of significant importance to public health. Specifically the Community Reinforcement and Family Training (CRAFT) procedures will be adapted, from reinforcing treatment entry, to reinforcing treatment retention and HIV risk behavior reduction in persons with opioid dependence who receive a Buprenorphine taper detoxification. The research plan includes three phases: 1) development of a manual guided therapy, 2) development of therapist training and fidelity measures and 3) a randomized pilot evaluation with 52 patients receiving either the new CRAFT treatment or treatment as usual.
Study Summary:  
Criteria:   Concerned Significant Other Inclusion Criteria: 1)be a first-degree relative, spouse, or intimate partner, or plan to live with the IP following the IP's detoxification, must plan to have contact with the IP at least 40% of the first 90 days post randomization, 2)be age 18 or older, 3)live within approximately 60 miles of Maryhaven, )be willing to participate in the protocol (i.e., to be randomized to treatment, to attend regular treatment sessions, to have their sessions audio taped, etc.), 5)be willing to sign a HIPAA-compliant release(s) of information to allow research staff access to any information collected from this subject during the study. Such staff may include RAs, therapists, supervisors, data managers, statisticians, QA personnel, etc., 6)be able to understand and provide written informed consent in English, 7)express desire to assist the IP with treatment retention and HIV risk behavior reduction. Concerned Significant Other Exclusion Criteria: 1) are unlikely to be available to complete the entire protocol (e.g., plan to relocate, intention to not continue if assigned to a perceived unattractive arm of the study), 2)have a condition (e.g., medical complications, psychiatric problems, etc.) that would necessitate inpatient treatment or would make study participation difficult, 3)have engaged in domestic violence or assault within the previous year or have a history of severe violence (i.e., use of a weapon or violence leading to a hospitalization). For the purposes of the present protocol, domestic violence is defined as any physical abuse between intimately involved partners, roommates, or family members, 4)are currently at risk for suicide as evidenced by presence of at least one of the following; a) a history of a suicide attempt(s) and current suicidal ideation, b) current suicide ideation including recurrent thoughts of suicide with intention to harm themselves, c) persistent or recurring desire to die, d) a plan to harm themselves, e) indication that they would not take steps to save their own life, 5)have been the victim of severe domestic violence (i.e., use of a weapon or violence leading to a hospitalization) by the IP. Identified Patient Inclusion Criteria: 1)be a first-degree relative, spouse, or intimate partner of the CSO, or someone who lives with the CSO, 2)be age 18 or older, 3)be currently enrolled in the BUP/NX 13-day taper protocol in Maryhaven's detoxification program, 4)intend to continue with outpatient treatment at Maryhaven, 5)be willing to participate in the protocol (i.e., to be randomized to treatment, to attend regular treatment sessions, to have their sessions audio taped, etc.), 6)be willing to sign a HIPAA compliant release(s) of information to allow research staff access to any information collected from this subject during the study. Such staff may include RAs, therapists, supervisors, data managers, statisticians, QA personnel, etc., 7)be able to understand and provide written informed consent in English, and 8)have a substance use disorder assessed by the Structured Clinical Interview for DSM-IV. Identified Patient Exclusion Criteria: 1)have engaged in domestic violence or assault within the previous year or have a history of severe violence (i.e., use of a weapon or violence leading to a hospitalization), 2)have a history of a suicide attempt(s)within the past year or current suicidal ideation, 3)are currently at risk for suicide as evidenced by presence of at least one of the following; (same as CSO suicide lethality criteria above), 4)have a condition (e.g., medical complications, or psychiatric problems other than substance abuse, etc.) that would necessitate residential/inpatient treatment or would make study participation difficult, 5)under a court order to enter and remain in treatment program.
NCT ID:   NCT00609089
Primary Contact:   Principal Investigator
Gregory S. Brigham, Ph.D.
University of Cincinnati

Backup Contact:   N/A
Location Contact:   Columbus, Ohio 43207
United States



There is no listed contact information for this specific location.

Site Status: N/A

Data Source:   ClinicalTrials.gov
Date Processed:   May 20, 2013
Modifications to this listing:   Only selected fields are shown, please use the link below to view all information about this clinical trial.
Click to view Full Listing


  • NEARBY STUDIES

Within 25 Miles

Vaginal Atrophy - Columbus OH

COPD - Columbus OH

Asthma - Columbus OH

Female Orgasmic Disorder - Columbus OH

Chronic Obstructive Pulmonary Disease (COPD) - Columbus OH

Birth Control - Columbus OH

Crohn's Disease - Columbus OH

Dust Mite Allergy - Columbus OH

Painful Menstrual Cramps - Columbus OH

Restless Legs Syndrome (RLS) - Dublin OH

Irritable Bowel Syndrome (with diarrhea) - Columbus OH

Low Back Pain and Constipation - Columbus OH

Low Back Pain and Constipation - Columbus OH

Brain Tumor (Glioblastoma) - Columbus OH

COPD (Emphysema and Chronic Bronchitis) - Columbus OH

Within 50 Miles

Irritable Bowel Syndrome (with diarrhea) - Marion OH

Within 100 Miles

Asthma - Cincinnati OH

Irritable Bowel Syndrome with Diarrhea (IBS-D) - Dayton OH

Arthritis - Mansfield OH

Arthritis - Englewood OH

Irritable Bowel Syndrome with Diarrhea (IBS-D) - Lima OH

Gout - Cincinnati OH

Restless Legs Syndrome (RLS) - Cincinnati OH

Irritable Bowel Syndrome (with diarrhea) - Englewood OH

Irritable Bowel Syndrome (with diarrhea) - Dayton OH

Irritable Bowel Syndrome (with diarrhea) - Dayton OH

Chronic Low Back Pain - Franklin OH

Chronic Low Back Pain - Cincinnati OH

Chronic Low Back Pain - Dayton OH

Multiple Sclerosis - Dayton OH

Asthma (Ages 18-65) - Cincinnati OH

Low Back Pain and Constipation - Dayton OH

Low Back Pain and Constipation - Dayton OH

Anti-Depressant Induced Sexual Dysfunction - Cincinnati OH

Anti-Depressant Induced Sexual Dysfunction - Cincinnati OH

Irritable Bowel Syndrome (with diarrhea) - Franklin OH

Irritable Bowel Syndrome (with diarrhea) - Cincinnati OH

Irritable Bowel Syndrome (with diarrhea) - Miamisburg OH

Irritable Bowel Syndrome (with diarrhea) - Zanesville OH

Uncontrolled Angina (Adult Stem Cell Research) - Cincinnati OH

Uncontrolled Angina (Adult Stem Cell Research) - Cincinnati OH

Brain Tumor (Glioblastoma) - Cincinnati OH

Arthritis - Tiffin OH

COPD (Emphysema and Chronic Bronchitis) - Cincinnati OH1

COPD (Emphysema and Chronic Bronchitis) - Cincinnati OH2

COPD (Emphysema and Chronic Bronchitis) - Cincinnati OH3

Low Back Pain and Constipation - Dayton OH

 
Clinical Connections Home | Investigators | CROs / Sponsors | Clinical Trials Notification | Search Clinical Trials | About Clinical Trials | Links | Terms And Conditions | Sitemap | Suggestions / Feedback
© 1998-2013 | All trademarks are property of their legal owners. | All Rights Reserved

ClinicalConnection.com is a resource that provides individuals with information regarding clinical trials that are being conducted worldwide.

ClinicalConnection.com does not conduct these clinical trials nor endorse them. Please consult your doctor or physician before participating.